Literature DB >> 10343889

Coronary heart disease. At the interface of molecular genetics and preventive medicine.

D L Ellsworth1, P Sholinsky, C Jaquish, R R Fabsitz, T A Manolio.   

Abstract

BACKGROUND: Susceptibility to common chronic diseases such as coronary heart disease (CHD) appears to be influenced by "context-dependent effects," which include interactions among genes (genetic epistasis) and among genes and environmental factors (gene-environment interactions).
METHODS: A synthesis of current knowledge and research findings demonstrates the importance of integrating genetic research on cardiovascular disease with preventive medicine and public health initiatives.
RESULTS: A variety of candidate genes have been implicated in risk for CHD, but only limited examples of context-dependent effects have been described. Interactions between genetic and environmental factors appear to influence lipid metabolism, plasma homocysteine levels, and pharmacologic response to many commonly prescribed medications. Quantification of genetic effects associated with increased disease risk that are modifiable by interventions such as diet, exercise, and smoking cessation is an important interface between molecular genetics and preventive medicine.
CONCLUSIONS: As a primary focus of preventive medicine expands to encompass early detection and treatment of asymptomatic individuals at risk for disease, the ability to quantify the influence of context-dependent effects on disease risk will be critical for determining drug safety and effectiveness in diverse patient populations and for implementing effective prevention and treatment programs.

Entities:  

Mesh:

Year:  1999        PMID: 10343889     DOI: 10.1016/s0749-3797(98)00138-x

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  9 in total

Review 1.  Context-dependent genetic effects in hypertension.

Authors:  S L Kardia
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

2.  Genetic information in the age of genohype.

Authors:  Péter Kakuk
Journal:  Med Health Care Philos       Date:  2006

3.  Genetic variants at the APOE, lipoprotein lipase (LpL), cholesteryl ester transfer protein (CETP), and endothelial nitric oxide (eNOS) genes and coronary artery disease (CAD): CETP Taq1 B2B2 associates with lower risk of CAD in Asian Indians.

Authors:  Aparna Amarendra Bhanushali; Bibhu R Das
Journal:  J Community Genet       Date:  2010-03-25

4.  Evidence for consistent intragenic and intergenic interactions between SNP effects in the APOA1/C3/A4/A5 gene cluster.

Authors:  Sara C Hamon; Sharon L R Kardia; Eric Boerwinkle; Kiang Liu; Kathy L E Klos; Andrew G Clark; Charles F Sing
Journal:  Hum Hered       Date:  2006-05-19       Impact factor: 0.444

5.  Lifestyle-related risk factors for total and cancer mortality in men and women.

Authors:  M Hara; M Mori; N Shono; Y Higaki; M Nishizumi
Journal:  Environ Health Prev Med       Date:  2000-10       Impact factor: 3.674

Review 6.  Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology.

Authors:  Joshua W Knowles; Themistocles L Assimes; Jun Li; Thomas Quertermous; John P Cooke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-07-26       Impact factor: 8.311

7.  Genetic loci for diet-induced atherosclerotic lesions and plasma lipids in mice.

Authors:  Veronica V Colinayo; Jian-Hua Qiao; Xuping Wang; Kelly L Krass; Eric Schadt; Aldons J Lusis; Thomas A Drake
Journal:  Mamm Genome       Date:  2003-07       Impact factor: 2.957

8.  Association of single Nucleotide Missence Polymorphism Val109Asp of Omentin-1 gene and coronary artery disease in Pakistani population: Multicenter study.

Authors:  Shazia Nazar; Sitwat Zehra; Abid Azhar
Journal:  Pak J Med Sci       Date:  2017 Sep-Oct       Impact factor: 1.088

Review 9.  The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis.

Authors:  Debbie A Lawlor; Ian N M Day; Tom R Gaunt; Lesley J Hinks; Patricia J Briggs; Matthew Kiessling; Nick Timpson; George Davey Smith; Shah Ebrahim
Journal:  BMC Genet       Date:  2004-06-23       Impact factor: 2.797

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.